awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37308941-4F912951-B5A8-46AF-ACBF-A8EB7A2C9080
Q37308941-4F912951-B5A8-46AF-ACBF-A8EB7A2C9080
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37308941-4F912951-B5A8-46AF-ACBF-A8EB7A2C9080
Empagliflozin/linagliptin single-tablet combination: first-in-class treatment option
P2860
Q37308941-4F912951-B5A8-46AF-ACBF-A8EB7A2C9080
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37308941-4F912951-B5A8-46AF-ACBF-A8EB7A2C9080
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
53962c9aa39b9912a542da89628c4749f03d9452
P2860
Combine and conquer: advantages and disadvantages of fixed-dose combination therapy.